Dendreon
Corporation (NASDAQ:DNDN) surged 0.62% to $37.59. The 52-week range of
the stock is $25.05-$57.67.
Dendreon
Corporation (Dendreon) is a biotechnology company focused on the discovery,
development and commercialization of therapeutics that may improve cancer
treatment options for patients.
Antigenics,
Inc. (NASDAQ:AGEN) fell 2.20% to $0.890. The 52-week range of the
stock is $0.60-$1.72.
Antigenics
Inc. is a biotechnology company developing and commercializing technologies to
treat cancers and infectious diseases, primarily based on immunological
approaches. Oncophage has been tested in Phase III clinical trials for the
treatment of renal cell carcinoma, the common type of kidney cancer, and for
the treatment of metastatic melanoma.
Sunesis
Pharmaceuticals, Inc. (NASDAQ:SNSS) plunged 7.47% to $0.400. The
52-week range of the stock is $0.29-$2.43. The stock is down more than 62%
year-to-date.
The stock has average daily volume of 2.41 million shares.
Article published by Wall Street Grand. Visit the Wall Street Grand Club today.
For our full disclosure please visit - http://www.wallstreetgrand.com/disclosure.html
